Investigational Drug Information for BMS-986166
✉ Email this page to a colleague
What is the drug development status for BMS-986166?
BMS-986166 is an investigational drug.
There have been 7 clinical trials for BMS-986166.
The most recent clinical trial was a Phase 1 trial, which was initiated on August 16th 2021.
The most common disease conditions in clinical trials are Eczema, Dermatitis, Atopic, and Dermatitis. The leading clinical trial sponsors are Bristol-Myers Squibb and [disabled in preview].
Summary for BMS-986166
| US Patents | 0 |
| International Patents | 35 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2021-08-16) |
| Vendors | 11 |
Recent Clinical Trials for BMS-986166
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants | Bristol-Myers Squibb | Phase 1 |
| A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis | Bristol-Myers Squibb | Phase 2 |
| A Study to Characterize the Pharmacokinetics of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential | Bristol-Myers Squibb | Phase 1 |
Clinical Trial Summary for BMS-986166
Top disease conditions for BMS-986166
Top clinical trial sponsors for BMS-986166
US Patents for BMS-986166
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BMS-986166
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BMS-986166 | Argentina | AR101591 | 2034-08-20 | ⤷ Subscribe |
| BMS-986166 | Australia | AU2015305501 | 2034-08-20 | ⤷ Subscribe |
| BMS-986166 | Brazil | BR112017002641 | 2034-08-20 | ⤷ Subscribe |
| BMS-986166 | Canada | CA2958560 | 2034-08-20 | ⤷ Subscribe |
| BMS-986166 | Chile | CL2017000382 | 2034-08-20 | ⤷ Subscribe |
| BMS-986166 | China | CN107148409 | 2034-08-20 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
